Biocon is currently trading at Rs. 397.05, up by 1.20 points or 0.30% from its previous closing of Rs. 395.85 on the BSE.
The scrip opened at Rs. 397.00 and has touched a high and low of Rs. 403.10 and Rs. 394.95 respectively. So far 111789 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 487.70 on 23-Dec-2020 and a 52 week low of Rs. 250.15 on 23-Mar-2020.
Last one week high and low of the scrip stood at Rs. 403.10 and Rs. 383.55 respectively. The current market cap of the company is Rs. 47742.00 crore.
The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 23.68% and 15.65% respectively.
Biocon has incorporated a wholly owned subsidiary company namely ‘Biofusion Therapeutics’ on March 18, 2021. The business of wholly owned subsidiary company would be in the field of Research and Development and allied services.
Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.
